A new study by the Employee Benefit Research Institute (EBRI) found that workers with employer-sponsored health insurance are paying an increasing share of their health care costs. This is driven, primarily, by the growth of the High Deductible Health Plans (HDHPs).

The median annual price of 13 new drugs approved this year by the U.S. Food and Drug Administration for chronic conditions is $257,000, according to a new analysis from Reuters. Additionally, seven other recently launched drugs are priced at more than $200,000 per year.

Some of the biggest hospital chains are seeing business rebound to pre-pandemic levels, but the industry as a whole is pressing for more federal relief before year’s end, citing inflation, labor and supply cost pressures. Why it matters: Hospitals are the biggest driver of U.S. health care spending, and the pandemic has tested Washington’s willingness to take on ...

After about two months of rapid spread, San Francisco appears to be turning a corner on monkeypox, with early data showing the local epidemic may be slowing down. The number of new cases reported each week hit a high of 143 the week of July 24 and has tapered each week since, first to 87 ...

The Biden administration is investing $98.9 million in grant funding to 59 returning Navigator organizations that assist consumers in picking an Affordable Care Act (ACA) exchange plan.

Dive Brief: * About 17% of enrollees in Medicaid and the Children’s Health Insurance Program, or 15 million people, could lose their coverage when states resume regular eligibility checks once the COVID-19 public health emergency ends, HHS projected in a report from the Office of the Assistant Secretary for Planning and Evaluation. * Loss of eligibility will require ...